Buyout group Carlyle is selling Swiss-headquartered clinic chain Ameos in a deal that will see the company’s founder and private equity firm Intermediate Capital Group (ICG) take full control, people close to the matter said. Founder and Chief Executive Axel Paeger will get a majority in the company’s voting rights, with a minority to be held by ICG and other co-investors, they said.
ICG, which was already an Ameos creditor, and the other investors will inject preference capital, mezzanine capital as well as debt into Ameos, allowing Carlyle and co-investor Quadriga to exit in steps by year-end, they added. The deal value could not be immediately obtained.
Ameos runs 96 acute general care and psychiatric hospitals and last year posted a net loss of 2 million euros ($2.4 million) on sales of 1.03 billion euros, after posting a 10.4 million net profit on revenue of 899 million in 2019. Carlyle invested in Ameos in 2011, with peer investor Quadriga Capital and founder and Paeger retaining stakes.
Reporting by Arno Schuetze; editing by Emelia Sithole-Matarise
Can't stop reading? This and all news articles are property of their creators, many are not owned or provided by Private Equity Insider. As an event organizer and community platform, we curate content from reliable sources for your suggested reading, and advise you to read the full articles from the referenced authors and sources.